Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants136

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants49

Views

Views
October 20253
November 20254
December 20256
January 202613
February 20260
March 202618
April 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States27
Brazil6
United Kingdom5
France2
Mexico2
Argentina2
Algeria1
Sweden1
Singapore1
Tunisia1
 

Top cities views

Views
San Jose12
Council Bluffs4
Ashburn1
Berthoud1
Blida1
Colorado Springs1
Ekerö1
Formosa1
Guadalupe1
Lawrenceville1